faculty_name,faculty_email,publication_type,title,journal,year,doi,url,file_created
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Recommending defunct therapies is a safety risk for hemophilia.,Blood Transfusion,2025,10.2450/BloodTransfus.982,https://experts.mcmaster.ca/display/publication3540487,2025-07-27T15:13:38.725630
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,"Pain-Related Quality of Life Outcomes in People With Haemophilia A Receiving Emicizumab: A Post Hoc Analysis of the HAVEN 1, 3 and 4 and STASEY Studies.",Haemophilia,2025,10.1111/hae.15134,https://experts.mcmaster.ca/display/publication3505266,2025-07-27T15:13:38.725633
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease.,Haemophilia,2024,10.1111/hae.15136,https://experts.mcmaster.ca/display/publication3494611,2025-07-27T15:13:38.725634
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical Appraisal.,Haemophilia,2024,10.1111/hae.15135,https://experts.mcmaster.ca/display/publication3494222,2025-07-27T15:13:38.725635
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,A core outcome set for prophylaxis and perioperative treatment of von Willebrand disease: The coreVWD initiative.,Haemophilia,2024,10.1111/hae.15122,https://experts.mcmaster.ca/display/publication3492767,2025-07-27T15:13:38.725636
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Development of the World Federation of Hemophilia Shared Decision-Making Tool.,Haemophilia,2024,10.1111/hae.15100,https://experts.mcmaster.ca/display/publication3477986,2025-07-27T15:13:38.725637
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Development of the coreHEM mental health patient-reported outcome measure - A novel mental health outlook measure for people with haemophilia.,Haemophilia,2024,10.1111/hae.15085,https://experts.mcmaster.ca/display/publication3470094,2025-07-27T15:13:38.725638
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines List,The Lancet Haematology,2024,10.1016/s2352-3026(24)00223-0,https://experts.mcmaster.ca/display/publication3460416,2025-07-27T15:13:38.725639
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,"Association of patient, treatment and disease characteristics with patient‐reported outcomes: Results of the ECHO Registry",Haemophilia,2024,10.1111/hae.14895,https://experts.mcmaster.ca/display/publication3320502,2025-07-27T15:13:38.725640
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1,Journal of Thrombosis and Haemostasis,2023,10.1016/j.jtha.2023.08.032,https://experts.mcmaster.ca/display/publication3290241,2025-07-27T15:13:38.725641
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,"Hemophilia gene therapy: first, do no harm",Journal of Thrombosis and Haemostasis,2023,10.1016/j.jtha.2023.06.016,https://experts.mcmaster.ca/display/publication3259128,2025-07-27T15:13:38.725642
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,"Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities in health services; diversity, equity, and inclusion; and implementation science",Expert Review of Hematology,2023,10.1080/17474086.2023.2183836,https://experts.mcmaster.ca/display/publication2981108,2025-07-27T15:13:38.725643
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Data sharing to advance gene‐targeted therapies in rare diseases,American Journal of Medical Genetics - Seminars in Medical Genetics,2023,10.1002/ajmg.c.32028,https://experts.mcmaster.ca/display/publication2658805,2025-07-27T15:13:38.725644
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,"Gene‐targeted therapies: Towards equitable development, diagnosis, and access",American Journal of Medical Genetics - Seminars in Medical Genetics,2023,10.1002/ajmg.c.32032,https://experts.mcmaster.ca/display/publication2777362,2025-07-27T15:13:38.725645
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Humanistic burden of problem joints for children and adults with haemophilia,Haemophilia,2023,10.1111/hae.14731,https://experts.mcmaster.ca/display/publication2658804,2025-07-27T15:13:38.725646
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature,Haemophilia,2023,10.1111/hae.14676,https://experts.mcmaster.ca/display/publication2440132,2025-07-27T15:13:38.725647
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia B,Journal of Medical Economics,2022,10.1080/13696998.2022.2049552,https://experts.mcmaster.ca/display/publication2178281,2025-07-27T15:13:38.725648
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years,The Lancet Haematology,2022,10.1016/s2352-3026(22)00209-5,https://experts.mcmaster.ca/display/publication2431417,2025-07-27T15:13:38.725649
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,"User-Centered Development and Testing of the Online Patient-Reported Outcomes, Burdens, and Experiences (PROBE) Survey and the myPROBE App and Integration With the Canadian Bleeding Disorder Registry: Mixed Methods Study",JMIR Human Factors,2022,10.2196/30797,https://experts.mcmaster.ca/display/publication2172480,2025-07-27T15:13:38.725650
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,A preliminary application of a haemophilia value framework to emerging therapies in haemophilia,Haemophilia,2022,10.1111/hae.14511,https://experts.mcmaster.ca/display/publication2178284,2025-07-27T15:13:38.725651
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,The Hemophilia Gene Therapy Patient Journey: Questions and Answers for Shared Decision-Making,Patient Preference and Adherence,2022,10.2147/ppa.s355627,https://experts.mcmaster.ca/display/publication2274074,2025-07-27T15:13:38.725652
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Eliminating Panglossian thinking in development of AAV therapeutics,Molecular Therapy,2021,10.1016/j.ymthe.2021.10.025,https://experts.mcmaster.ca/display/publication2154110,2025-07-27T15:13:38.725652
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Evaluation of the sexual health in people living with hemophilia,Haemophilia,2021,10.1111/hae.14410,https://experts.mcmaster.ca/display/publication2129783,2025-07-27T15:13:38.725653
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Patient preferences and priorities for haemophilia gene therapy in the US: A discrete choice experiment,Haemophilia,2021,10.1111/hae.14383,https://experts.mcmaster.ca/display/publication2049462,2025-07-27T15:13:38.725654
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,"The effect of emicizumab prophylaxis on long‐term, self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies",Haemophilia,2021,10.1111/hae.14363,https://experts.mcmaster.ca/display/publication1987173,2025-07-27T15:13:38.725655
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Evolution of haemophilia integrated care in the era of gene therapy: Treatment centre’s readiness in United States and EU,Haemophilia,2021,10.1111/hae.14309,https://experts.mcmaster.ca/display/publication1967597,2025-07-27T15:13:38.725656
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,"Vaccination against COVID‐19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders",Haemophilia,2021,10.1111/hae.14271,https://experts.mcmaster.ca/display/publication1960659,2025-07-27T15:13:38.725657
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set,Research and Practice in Thrombosis and Haemostasis,2021,10.1002/rth2.12488,https://experts.mcmaster.ca/display/publication1963914,2025-07-27T15:13:38.725658
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Evidence of a disability paradox in patient‐reported outcomes in haemophilia,Haemophilia,2021,10.1111/hae.14278,https://experts.mcmaster.ca/display/publication1959641,2025-07-27T15:13:38.725659
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Identified unmet needs and proposed solutions in mild‐to‐moderate haemophilia: A summary of opinions from a roundtable of haemophilia experts,Haemophilia,2021,10.1111/hae.14168,https://experts.mcmaster.ca/display/publication1958361,2025-07-27T15:13:38.725660
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation Disorders,Journal of Blood Medicine,2021,10.2147/jbm.s325031,https://experts.mcmaster.ca/display/publication2142543,2025-07-27T15:13:38.725661
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Non‐severe haemophilia: Is it benign? – Insights from the PROBE study,Haemophilia,2021,10.1111/hae.14105,https://experts.mcmaster.ca/display/publication1923964,2025-07-27T15:13:38.725662
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Personalising haemophilia management with shared decision making,The Journal of Haemophilia Practice,2021,10.17225/jhp00178,https://experts.mcmaster.ca/display/publication3561871,2025-07-27T15:13:38.725663
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,The potential impact of gene therapy on health-related quality of life (HRQoL) domains in haemophilia,The Journal of Haemophilia Practice,2021,10.17225/jhp00176,https://experts.mcmaster.ca/display/publication3561872,2025-07-27T15:13:38.725664
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company,Haemophilia,2020,10.1111/hae.14144,https://experts.mcmaster.ca/display/publication1936087,2025-07-27T15:13:38.725665
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,"Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH",Journal of Thrombosis and Haemostasis,2020,10.1111/jth.15023,https://experts.mcmaster.ca/display/publication1937783,2025-07-27T15:13:38.725666
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Gene therapy to cure haemophilia: Is robust scientific inquiry the missing factor?,Haemophilia,2020,10.1111/hae.14131,https://experts.mcmaster.ca/display/publication1925854,2025-07-27T15:13:38.725667
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,The role of telemedicine in the delivery of health care in the COVID‐19 pandemic,Haemophilia,2020,10.1111/hae.14044,https://experts.mcmaster.ca/display/publication1894317,2025-07-27T15:13:38.725668
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,The World Federation of Hemophilia Annual Global Survey 1999‐2018,Haemophilia,2020,10.1111/hae.14012,https://experts.mcmaster.ca/display/publication1914356,2025-07-27T15:13:38.725669
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,World Federation of Hemophilia Gene Therapy Registry,Haemophilia,2020,10.1111/hae.14015,https://experts.mcmaster.ca/display/publication1910847,2025-07-27T15:13:38.725669
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Achieving the unimaginable: Health equity in haemophilia,Haemophilia,2020,10.1111/hae.13862,https://experts.mcmaster.ca/display/publication1679558,2025-07-27T15:13:38.725670
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,An international survey to inform priorities for new guidelines on von Willebrand disease,Haemophilia,2020,10.1111/hae.13881,https://experts.mcmaster.ca/display/publication1680493,2025-07-27T15:13:38.725671
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,"Exploring regional variations in the cross‐cultural, international implementation of the Patient Reported Outcomes Burdens and Experience (PROBE) study",Haemophilia,2019,10.1111/hae.13703,https://experts.mcmaster.ca/display/publication1634148,2025-07-27T15:13:38.725672
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Hemophilia trials in the twenty‐first century: Defining patient important outcomes,Research and Practice in Thrombosis and Haemostasis,2019,10.1002/rth2.12195,https://experts.mcmaster.ca/display/publication1639469,2025-07-27T15:13:38.725673
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,The 1stWFHGene Therapy Round Table: Understanding the landscape and challenges of gene therapy for haemophilia around the world,Haemophilia,2019,10.1111/hae.13673,https://experts.mcmaster.ca/display/publication1751434,2025-07-27T15:13:38.725674
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,"Test‐retest properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire and its constituent domains",Haemophilia,2019,10.1111/hae.13649,https://experts.mcmaster.ca/display/publication1612046,2025-07-27T15:13:38.725675
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,"The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia",Pilot and Feasibility Studies,2018,10.1186/s40814-018-0253-0,https://experts.mcmaster.ca/display/publication1505309,2025-07-27T15:13:38.725676
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,"Aging Through the Lens of Historical Time, Space, and Place",The Gerontologist,2018,10.1093/geront/gny070,https://experts.mcmaster.ca/display/publication1728103,2025-07-27T15:13:38.725677
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Core outcome set for gene therapy in haemophilia: Results of the coreHEMmultistakeholder project,Haemophilia,2018,10.1111/hae.13504,https://experts.mcmaster.ca/display/publication1534544,2025-07-27T15:13:38.725678
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,"Genotypes, phenotypes and whole genome sequence: Approaches from theMy Life Our Futurehaemophilia project",Haemophilia,2018,10.1111/hae.13506,https://experts.mcmaster.ca/display/publication1635782,2025-07-27T15:13:38.725679
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Establishing the appropriate primary endpoint in haemophilia gene therapy pivotal studies,Haemophilia,2017,10.1111/hae.13313,https://experts.mcmaster.ca/display/publication1635783,2025-07-27T15:13:38.725680
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Risk‐based decision making and ethical considerations in donor compensation for plasma‐derived medicinal products,Transfusion,2016,10.1111/trf.13764,https://experts.mcmaster.ca/display/publication1635794,2025-07-27T15:13:38.725681
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Improving comprehensive care in the haemophilia community: building on theHEROStudy,Haemophilia,2016,10.1111/hae.12945,https://experts.mcmaster.ca/display/publication1635784,2025-07-27T15:13:38.725682
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,NHF‐McMaster Guideline on Care Models for Haemophilia Management,Haemophilia,2016,10.1111/hae.13008,https://experts.mcmaster.ca/display/publication172779,2025-07-27T15:13:38.725683
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Assessments of outcome in haemophilia – a patient perspective,Haemophilia,2016,10.1111/hae.12922,https://experts.mcmaster.ca/display/publication1635785,2025-07-27T15:13:38.725684
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,"The national haemophilia program standards, evaluation and oversight systems in the United States of America.",Blood Transfusion,2014,10.2450/2014.0019-14s,https://experts.mcmaster.ca/display/publication1635797,2025-07-27T15:13:38.725685
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,World Federation of Hemophilia: 50 years of advancing treatment for all,Haemophilia,2013,10.1111/hae.12200,https://experts.mcmaster.ca/display/publication1635786,2025-07-27T15:13:38.725686
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Factor VIII Products and Inhibitors in Severe Hemophilia A,New England Journal of Medicine,2013,10.1056/nejmc1301995,https://experts.mcmaster.ca/display/publication411185,2025-07-27T15:13:38.725687
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Factor VIII products and inhibitors in severe hemophilia A.,New England Journal of Medicine,2013,10.1056/NEJMc1301995,https://experts.mcmaster.ca/display/publication172957,2025-07-27T15:13:38.725688
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Gene Therapy for Hemophilia: Addressing the Coming Challenges of Affordability and Accessibility,Molecular Therapy,2013,10.1038/mt.2012.272,https://experts.mcmaster.ca/display/publication1635787,2025-07-27T15:13:38.725689
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: The Transthyretin Amyloidosis Cardiac Study (TRACS),American Heart Journal,2012,10.1016/j.ahj.2012.04.015,https://experts.mcmaster.ca/display/publication1635888,2025-07-27T15:13:38.725690
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,"Haemophilia care – past, present and future from a patient perspective",Haemophilia,2012,10.1111/j.1365-2516.2012.02892.x,https://experts.mcmaster.ca/display/publication1635788,2025-07-27T15:13:38.725691
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,WFH: Closing the global gap – achieving optimal care,Haemophilia,2012,10.1111/j.1365-2516.2012.02822.x,https://experts.mcmaster.ca/display/publication1635802,2025-07-27T15:13:38.725692
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Ensuring maximum outcomes and benefits in comprehensive care for bleeding disorders through surveillance and data collection,Hematology,2012,10.1179/102453312x13336169156573,https://experts.mcmaster.ca/display/publication1635807,2025-07-27T15:13:38.725693
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Cell Phones and Landlines: The Impact of Gene Therapy on the Cost and Availability of Treatment for Hemophilia,Molecular Therapy,2011,10.1038/mt.2011.203,https://experts.mcmaster.ca/display/publication1751606,2025-07-27T15:13:38.725694
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Haemophilia: provision of factors and novel therapies: World Federation of Hemophilia goals and achievements,British Journal of Haematology,2011,10.1111/j.1365-2141.2011.08765.x,https://experts.mcmaster.ca/display/publication1635789,2025-07-27T15:13:38.725695
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Building our global family – achieving treatment for all,Haemophilia,2010,10.1111/j.1365-2516.2010.02285.x,https://experts.mcmaster.ca/display/publication1635790,2025-07-27T15:13:38.725696
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Global data and haemophilia care trends: commentary,Haemophilia,2010,10.1111/j.1365-2516.2009.02177.x,https://experts.mcmaster.ca/display/publication1635806,2025-07-27T15:13:38.725697
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,WFH – the cornerstone of global development: 45 years of progress,Haemophilia,2008,10.1111/j.1365-2516.2008.01707.x,https://experts.mcmaster.ca/display/publication1635791,2025-07-27T15:13:38.725698
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,Treatment for all: a vision for the future,Haemophilia,2006,10.1111/j.1365-2516.2006.01280.x,https://experts.mcmaster.ca/display/publication1635792,2025-07-27T15:13:38.725699
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,More on: are randomized clinical trials the only truth? Not always,Journal of Thrombosis and Haemostasis,2006,10.1111/j.1538-7836.2006.01938.x,https://experts.mcmaster.ca/display/publication1635830,2025-07-27T15:13:38.725700
Mark Skinner,skinnm5@mcmaster.ca,journal_articles,What is a cure and how do we get there?,Haemophilia,2004,10.1111/j.1365-2516.2004.00999.x,https://experts.mcmaster.ca/display/publication1635824,2025-07-27T15:13:38.725701
Mark Skinner,skinnm5@mcmaster.ca,chapters,Geographical gerontology: Progress and possibilities,,2017,10.4324/9781315281216,https://experts.mcmaster.ca/display/publication1728053,2025-07-27T15:13:38.725702
Mark Skinner,skinnm5@mcmaster.ca,chapters,"Space and place in geographical gerontology: Theoretical traditions, formations of hope",,2017,10.4324/9781315281216,https://experts.mcmaster.ca/display/publication1728054,2025-07-27T15:13:38.725703
Mark Skinner,skinnm5@mcmaster.ca,chapters,Ageing Resource Communities,,2015,10.4324/9781315728209,https://experts.mcmaster.ca/display/publication1751634,2025-07-27T15:13:38.725704
Mark Skinner,skinnm5@mcmaster.ca,chapters,Perspectives on rural voluntarism,,2015,10.4324/9781315728209,https://experts.mcmaster.ca/display/publication1751640,2025-07-27T15:13:38.725705
Mark Skinner,skinnm5@mcmaster.ca,chapters,"Aging and Older People, Geography of",,2015,10.1016/b978-0-08-097086-8.72115-5,https://experts.mcmaster.ca/display/publication1728052,2025-07-27T15:13:38.725706
Mark Skinner,skinnm5@mcmaster.ca,chapters,Comprehensive care and delivery of care: the global perspective,,2014,,https://experts.mcmaster.ca/display/publication3261927,2025-07-27T15:13:38.725707
Mark Skinner,skinnm5@mcmaster.ca,conferences,Test–retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study,Haemophilia,2024,10.1111/hae.14969,https://experts.mcmaster.ca/display/publication995654,2025-07-27T15:13:38.725708
Mark Skinner,skinnm5@mcmaster.ca,conferences,Initial results of the impact of valoctocogene roxaparvovec on pain occurrence and interference: Insights from PROBE,Haemophilia,2023,,https://experts.mcmaster.ca/display/publication3277051,2025-07-27T15:13:38.725709
Mark Skinner,skinnm5@mcmaster.ca,conferences,"A COMPARATIVE STUDY OF DIFFERENT METHODS OF HANDLING MISSING DATA IN PATIENT REPORTED OUTCOMES, BURDENS AND EXPERIENCES (PROBE) SCORE ALGORITHM AMONG PEOPLE WITH HEMOPHILIA",American Journal of Hematology,2023,,https://experts.mcmaster.ca/display/publication2980744,2025-07-27T15:13:38.725710
Mark Skinner,skinnm5@mcmaster.ca,conferences,COLLABORATION FOR THE LONG-TERM FOLLOW-UP OF PEOPLE WITH HEMOPHILIA TREATED WITH GENE THERAPY: WORLD FEDERATION OF HEMOPHILIA- AMERICAN THROMBOSIS AND HEMOSTASIS NETWORK,American Journal of Hematology,2023,,https://experts.mcmaster.ca/display/publication2981099,2025-07-27T15:13:38.725711
Mark Skinner,skinnm5@mcmaster.ca,conferences,NATIONAL ECONOMIC BURDEN OF ADULTS WITH SEVERE HEMOPHILIA A MANAGED WITH PROPHYLAXIS IN THE UNITED STATES,American Journal of Hematology,2023,,https://experts.mcmaster.ca/display/publication2981098,2025-07-27T15:13:38.725712
Mark Skinner,skinnm5@mcmaster.ca,conferences,"A Novel Methodology for Building Longitudinal, PatientCentric Real World Datasets in Hemophilia A",Blood,2021,10.1182/blood-2021-146160Get,https://experts.mcmaster.ca/display/publication2429824,2025-07-27T15:13:38.725713
Mark Skinner,skinnm5@mcmaster.ca,conferences,Relationship of EQ-5D Pain Domain and Bleeds - Insights from the PROBE Study,Haemophilia,2021,,https://experts.mcmaster.ca/display/publication2122576,2025-07-27T15:13:38.725714
Mark Skinner,skinnm5@mcmaster.ca,conferences,THE WORLD FEDERATION OF HEMOPHILIA GENE THERAPY REGISTRY,Haemophilia,2021,,https://experts.mcmaster.ca/display/publication1962004,2025-07-27T15:13:38.725715
Mark Skinner,skinnm5@mcmaster.ca,conferences,"Examination and Validation of a Patient-Centric Joint Metric: ""Problem Joint""; Empirical Evidence from the CHESS US Dataset",Blood,2020,10.1182/blood-2020-140950,https://experts.mcmaster.ca/display/publication1979439,2025-07-27T15:13:38.725716
Mark Skinner,skinnm5@mcmaster.ca,conferences,Developing a patient reported outcome measure to explore mental health outlook in people with Hemophilia: Development of a conceptual framework,Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1915794,2025-07-27T15:13:38.725717
Mark Skinner,skinnm5@mcmaster.ca,conferences,Education in people with Hemophilia - Insights from the PROBE Study,Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1914746,2025-07-27T15:13:38.725718
Mark Skinner,skinnm5@mcmaster.ca,conferences,Impact of Pain on Physical Activity by Persons with Hemophilia (PwH) from the HemACTIVE Patient Survey,Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1915792,2025-07-27T15:13:38.725719
Mark Skinner,skinnm5@mcmaster.ca,conferences,International Standard Set of Health Outcomes that matter for people living with hemophilia,Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1914745,2025-07-27T15:13:38.725720
Mark Skinner,skinnm5@mcmaster.ca,conferences,Quantifying the disability paradox in hemophilia,Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1915791,2025-07-27T15:13:38.725721
Mark Skinner,skinnm5@mcmaster.ca,conferences,Treatment adherence in people with hemophilia (PwH) who are restricted by pain: Findings from the HemACTIVE Patient Survey,Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1915793,2025-07-27T15:13:38.725722
Mark Skinner,skinnm5@mcmaster.ca,conferences,DEVELOPMENT AND TESTING OF THE ONLINE PROBE SURVEY AND THE MYPROBE APP AND INTEGRATION WITH THE CANADIAN BLEEDING DISORDER REGISTRY,Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1692273,2025-07-27T15:13:38.725723
Mark Skinner,skinnm5@mcmaster.ca,conferences,"coreHEM, a Multistakeholder Core Outcome Set Project for Gene Therapy in Hemophilia",Molecular Therapy,2019,,https://experts.mcmaster.ca/display/publication1639464,2025-07-27T15:13:38.725724
Mark Skinner,skinnm5@mcmaster.ca,conferences,"""Problem Joint"" a more patient relevant definition for joint morbidity in haemophilia",Haemophilia,2019,,https://experts.mcmaster.ca/display/publication1628471,2025-07-27T15:13:38.725725
Mark Skinner,skinnm5@mcmaster.ca,conferences,Impact of acute and chronic pain on the EQ-5D: Insights from the PROBE study,Haemophilia,2019,,https://experts.mcmaster.ca/display/publication1628468,2025-07-27T15:13:38.725726
Mark Skinner,skinnm5@mcmaster.ca,conferences,Part-time employment and early retirement in people with severe haemophilia: Insights from the PROBE study,Haemophilia,2019,,https://experts.mcmaster.ca/display/publication1628469,2025-07-27T15:13:38.725727
Mark Skinner,skinnm5@mcmaster.ca,conferences,"Physical activity in persons with hemophilia (PwH) from France (FR), Italy (ITA), and United States (US) from the hemactive patient survey",Haemophilia,2019,,https://experts.mcmaster.ca/display/publication1628467,2025-07-27T15:13:38.725728
Mark Skinner,skinnm5@mcmaster.ca,conferences,Predictors for acute and chronic pain in patients with severe haemophilia in the PROBE cohort,Haemophilia,2019,,https://experts.mcmaster.ca/display/publication1628470,2025-07-27T15:13:38.725729
Mark Skinner,skinnm5@mcmaster.ca,conferences,First Steps in Choosing Appropriate Instruments/Measurements for a Core Outcome Set: An Example from Corehem,Value in Health,2018,10.1016/j.jval.2018.04.1439,https://experts.mcmaster.ca/display/publication1581308,2025-07-27T15:13:38.725730
Mark Skinner,skinnm5@mcmaster.ca,conferences,The PROBE Data Dashboard - A new tool for real-time data visualization and analysis of patient reported outcomes,Haemophilia,2018,,https://experts.mcmaster.ca/display/publication1543698,2025-07-27T15:13:38.725731
Mark Skinner,skinnm5@mcmaster.ca,conferences,The PROBE Study - Global burden of bleeding from the mouth in Haemophilia - a call to action,Haemophilia,2018,,https://experts.mcmaster.ca/display/publication1543701,2025-07-27T15:13:38.725732
Mark Skinner,skinnm5@mcmaster.ca,conferences,coreHEM: A multi-stakeholder approach to developing a core outcome set for gene therapy in hemophilia,Haemophilia,2018,,https://experts.mcmaster.ca/display/publication1543702,2025-07-27T15:13:38.725733
Mark Skinner,skinnm5@mcmaster.ca,conferences,"Occurrence and impact of pain among patients living with hemophilia: An analysis from the patient reported outcomes, burdens and experiences (PROBE) study",Haemophilia,2018,,https://experts.mcmaster.ca/display/publication1498586,2025-07-27T15:13:38.725733
Mark Skinner,skinnm5@mcmaster.ca,conferences,"Burden of Comorbid Diseases in Patients with Hemophilia: The Cross-Sectional Analysis of the Patient Reported Outcomes, Burden and Experiences (PROBE) Study",Blood,2017,,https://experts.mcmaster.ca/display/publication1979440,2025-07-27T15:13:38.725734
Mark Skinner,skinnm5@mcmaster.ca,conferences,"Sexual Health in Patients with Hemophilia; The Insights from the Patient Reported Outcomes, Burdens and Experiences (PROBE) Study",Blood,2017,,https://experts.mcmaster.ca/display/publication1979441,2025-07-27T15:13:38.725735
Mark Skinner,skinnm5@mcmaster.ca,conferences,Estimating The Global Annual Bleed Rate In Haemophilia,Haemophilia,2017,,https://experts.mcmaster.ca/display/publication1635883,2025-07-27T15:13:38.725736
Mark Skinner,skinnm5@mcmaster.ca,conferences,Test-Retest Reliability Analysis of the Patient Reported Outcomes Burdens and Experiences (PROBE),Blood,2016,10.1182/blood.v128.22.5964.5964,https://experts.mcmaster.ca/display/publication995651,2025-07-27T15:13:38.725737
Mark Skinner,skinnm5@mcmaster.ca,conferences,NHF-MCMASTER GUIDELINE ON CARE MODELS FOR HEMOPHILIA MANAGEMENT,American Journal of Hematology,2016,,https://experts.mcmaster.ca/display/publication626825,2025-07-27T15:13:38.725738
Mark Skinner,skinnm5@mcmaster.ca,conferences,A risk based decision making framework - stakeholder consultation essential to appropriate minimization of blood safety risk,Haemophilia,2016,,https://experts.mcmaster.ca/display/publication1383708,2025-07-27T15:13:38.725739
Mark Skinner,skinnm5@mcmaster.ca,conferences,Development of a questionnaire to identify hemophilia A patient and clinician discussion opportunities around prophylaxis treatment options,Haemophilia,2016,,https://experts.mcmaster.ca/display/publication1635831,2025-07-27T15:13:38.725740
Mark Skinner,skinnm5@mcmaster.ca,conferences,The patient reported outcomes burdens and experiences (PROBE) study phase 1 methodology and feasibility results,Haemophilia,2016,,https://experts.mcmaster.ca/display/publication995670,2025-07-27T15:13:38.725741
Mark Skinner,skinnm5@mcmaster.ca,conferences,The patient reported outcome burdens and experiences (PROBE) study - phase 1 results show PROBE study methodology feasible,Journal of Thrombosis and Haemostasis,2016,,https://experts.mcmaster.ca/display/publication995693,2025-07-27T15:13:38.725742
Mark Skinner,skinnm5@mcmaster.ca,conferences,"The Patient Reported Outcomes, Burdens, and Experiences (Probe) Phase 1 Study Methodology and Feasibility",Haemophilia,2016,,https://experts.mcmaster.ca/display/publication995689,2025-07-27T15:13:38.725743
Mark Skinner,skinnm5@mcmaster.ca,conferences,Cultivating and Preparing Future Leaders,Haemophilia,2014,,https://experts.mcmaster.ca/display/publication1635832,2025-07-27T15:13:38.725744
Mark Skinner,skinnm5@mcmaster.ca,conferences,Speaking as one voice: Uniting and educating advocates,Haemophilia,2014,,https://experts.mcmaster.ca/display/publication1635834,2025-07-27T15:13:38.725745
Mark Skinner,skinnm5@mcmaster.ca,conferences,The Rise of the Patient Voice,Haemophilia,2014,,https://experts.mcmaster.ca/display/publication1635833,2025-07-27T15:13:38.725746
Mark Skinner,skinnm5@mcmaster.ca,conferences,Hemophilia and von Willebrand disease patients' perceptions of care at US Hemophilia Treatment Centers,Haemophilia,2014,,https://experts.mcmaster.ca/display/publication1635887,2025-07-27T15:13:38.725747
Mark Skinner,skinnm5@mcmaster.ca,conferences,Morbidity and Mortality of Transthyretin (TTR) Amyloid Cardiomyopathy (ATTR-CM): Transthyretin Amyloidosis Cardiac Study (TRACS) a Prospective Evaluation,Circulation,2008,,https://experts.mcmaster.ca/display/publication1635857,2025-07-27T15:13:38.725748
Mark Skinner,skinnm5@mcmaster.ca,conferences,"Global Forum of the World Federation of Hemophilia, September 26–27, 2005, Montreal, Quebec, Canada",Transfusion and Apheresis Science,2006,10.1016/j.transci.2006.07.003,https://experts.mcmaster.ca/display/publication1751584,2025-07-27T15:13:38.725749
Mark Skinner,skinnm5@mcmaster.ca,other,Geographical Gerontology,,2017,10.4324/9781315281216,https://experts.mcmaster.ca/display/publication1728051,2025-07-27T15:13:38.725750
Mark Skinner,skinnm5@mcmaster.ca,other,Preface,,2015,10.4324/9781315728209,https://experts.mcmaster.ca/display/publication1751635,2025-07-27T15:13:38.725751
Mark Skinner,skinnm5@mcmaster.ca,preprints,"User-Centered Development and Testing of the Online Patient-Reported Outcomes, Burdens, and Experiences (PROBE) Survey and the myPROBE App and Integration With the Canadian Bleeding Disorder Registry: Mixed Methods Study (Preprint)",,2021,10.2196/preprints.30797,https://experts.mcmaster.ca/display/publication3285816,2025-07-27T15:13:38.725752
